As of April 26, 2023, among adults 18-29 years, the total number of cases of COVID-19 has reached almost 19.48million. This statistic illustrates the total number of cases of COVID-19 in the United States as of April 26, 2023, by age group.

As of April 26, 2023, roughly 367 million Pfizer-BioNTech COVID-19 vaccine doses had been administered in the United States. This statistic shows the number of COVID-19 vaccinations administered in the United States as of April 26, 2023, by manufacturer.

COVID-19 has spread to most regions and territories around the world. As of May 2, 2023, the number of confirmed cases had reached roughly 687 million.

COVID-19 in the Americas The Americas is one of the regions most impacted by COVID-19. The number of coronavirus cases and deaths are particularly high in the United States and Brazil. The pandemic has had a devastating impact on Latin America, and several nations have recorded a resurgence in cases, highlighting the complexity of easing restrictions while the virus is still a threat. However, mass vaccination programs have been launched in countries including Argentina, Chile, and Panama.

The role of face masks in the prevention of COVID-19 There has been much discussion about the effectiveness of face masks in slowing the spread of the COVID-19 disease. Many governments around the world made it mandatory to wear a form of face mask, particularly in shops and on public transport. Masks alone will not halt the spread of the disease, and they should be used alongside other measures such as social distancing.

After May 3, 2024, this dataset and webpage will no longer be updated because hospitals are no longer required to report data on COVID-19 hospital admissions, and hospital capacity and occupancy data, to HHS through CDC’s National Healthcare Safety Network. Data voluntarily reported to NHSN after May 1, 2024, will be available starting May 10, 2024, at COVID Data Tracker Hospitalizations.

The following dataset provides facility-level data for hospital utilization aggregated on a weekly basis (Sunday to Saturday). These are derived from reports with facility-level granularity across two main sources: (1) HHS TeleTracking, and (2) reporting provided directly to HHS Protect by state/territorial health departments on behalf of their healthcare facilities.

The hospital population includes all hospitals registered with Centers for Medicare & Medicaid Services (CMS) as of June 1, 2020. It includes non-CMS hospitals that have reported since July 15, 2020. It does not include psychiatric, rehabilitation, Indian Health Service (IHS) facilities, U.S. Department of Veterans Affairs (VA) facilities, Defense Health Agency (DHA) facilities, and religious non-medical facilities.

For a given entry, the term “collection_week” signifies the start of the period that is aggregated. For example, a “collection_week” of 2020-11-15 means the average/sum/coverage of the elements captured from that given facility starting and including Sunday, November 15, 2020, and ending and including reports for Saturday, November 21, 2020.

Reported elements include an append of either “_coverage”, “_sum”, or “_avg”.

• A “_coverage” append denotes how many times the facility reported that element during that collection week.
• A “_sum” append denotes the sum of the reports provided for that facility for that element during that collection week.
• A “_avg” append is the average of the reports provided for that facility for that element during that collection week.

The file will be updated weekly. No statistical analysis is applied to impute non-response. For averages, calculations are based on the number of values collected for a given hospital in that collection week. Suppression is applied to the file for sums and averages less than four (4). In these cases, the field will be replaced with “-999,999”.

A story page was created to display both corrected and raw datasets and can be accessed at this link: https://healthdata.gov/stories/s/nhgk-5gpv

This data is preliminary and subject to change as more data become available. Data is available starting on July 31, 2020.

Sometimes, reports for a given facility will be provided to both HHS TeleTracking and HHS Protect. When this occurs, to ensure that there are not duplicate reports, deduplication is applied according to prioritization rules within HHS Protect.

For influenza fields listed in the file, the current HHS guidance marks these fields as optional. As a result, coverage of these elements are varied.

For recent updates to the dataset, scroll to the bottom of the dataset description.

On May 3, 2021, the following fields have been added to this data set.

• hhs_ids
• previous_day_admission_adult_covid_confirmed_7_day_coverage
• previous_day_admission_pediatric_covid_confirmed_7_day_coverage
• previous_day_admission_adult_covid_suspected_7_day_coverage
• previous_day_admission_pediatric_covid_suspected_7_day_coverage
• previous_week_personnel_covid_vaccinated_doses_administered_7_day_sum
• total_personnel_covid_vaccinated_doses_none_7_day_sum
• total_personnel_covid_vaccinated_doses_one_7_day_sum
• total_personnel_covid_vaccinated_doses_all_7_day_sum
• previous_week_patients_covid_vaccinated_doses_one_7_day_sum
• previous_week_patients_covid_vaccinated_doses_all_7_day_sum

On May 8, 2021, this data set has been converted to a corrected data set. The corrections applied to this data set are to smooth out data anomalies caused by keyed in data errors. To help determine which records have had corrections made to it. An additional Boolean field called is_corrected has been added.

On May 13, 2021 Changed vaccination fields from sum to max or min fields. This reflects the maximum or minimum number reported for that metric in a given week.

On June 7, 2021 Changed vaccination fields from max or min fields to Wednesday reported only. This reflects that the number reported for that metric is only reported on Wednesdays in a given week.

On September 20, 2021, the following has been updated: The use of analytic dataset as a source.

On January 19, 2022, the following fields have been added to this dataset:

• inpatient_beds_used_covid_7_day_avg
• inpatient_beds_used_covid_7_day_sum
• inpatient_beds_used_covid_7_day_coverage

On April 28, 2022, the following pediatric fields have been added to this dataset:

• all_pediatric_inpatient_bed_occupied_7_day_avg
• all_pediatric_inpatient_bed_occupied_7_day_coverage
• all_pediatric_inpatient_bed_occupied_7_day_sum
• all_pediatric_inpatient_beds_7_day_avg
• all_pediatric_inpatient_beds_7_day_coverage
• all_pediatric_inpatient_beds_7_day_sum
• previous_day_admission_pediatric_covid_confirmed_0_4_7_day_sum
• previous_day_admission_pediatric_covid_confirmed_12_17_7_day_sum
• previous_day_admission_pediatric_covid_confirmed_5_11_7_day_sum
• previous_day_admission_pediatric_covid_confirmed_unknown_7_day_sum
• staffed_icu_pediatric_patients_confirmed_covid_7_day_avg
• staffed_icu_pediatric_patients_confirmed_covid_7_day_coverage
• staffed_icu_pediatric_patients_confirmed_covid_7_day_sum
• staffed_pediatric_icu_bed_occupancy_7_day_avg
• staffed_pediatric_icu_bed_occupancy_7_day_coverage
• staffed_pediatric_icu_bed_occupancy_7_day_sum
• total_staffed_pediatric_icu_beds_7_day_avg
• total_staffed_pediatric_icu_beds_7_day_coverage
• total_staffed_pediatric_icu_beds_7_day_sum

On October 24, 2022, the data includes more analytical calculations in efforts to provide a cleaner dataset. For a raw version of this dataset, please follow this link: https://healthdata.gov/Hospital/COVID-19-Reported-Patient-Impact-and-Hospital-Capa/uqq2-txqb

Due to changes in reporting requirements, after June 19, 2023, a collection week is defined as starting on a Sunday and ending on the next Saturday.

Note: Reporting of new COVID-19 Case Surveillance data will be discontinued July 1, 2024, to align with the process of removing SARS-CoV-2 infections (COVID-19 cases) from the list of nationally notifiable diseases. Although these data will continue to be publicly available, the dataset will no longer be updated.

Authorizations to collect certain public health data expired at the end of the U.S. public health emergency declaration on May 11, 2023. The following jurisdictions discontinued COVID-19 case notifications to CDC: Iowa (11/8/21), Kansas (5/12/23), Kentucky (1/1/24), Louisiana (10/31/23), New Hampshire (5/23/23), and Oklahoma (5/2/23). Please note that these jurisdictions will not routinely send new case data after the dates indicated. As of 7/13/23, case notifications from Oregon will only include pediatric cases resulting in death.

This case surveillance public use dataset has 12 elements for all COVID-19 cases shared with CDC and includes demographics, any exposure history, disease severity indicators and outcomes, presence of any underlying medical conditions and risk behaviors, and no geographic data.

CDC has three COVID-19 case surveillance datasets:

• COVID-19 Case Surveillance Public Use Data with Geography: Public use, patient-level dataset with clinical data (including symptoms), demographics, and county and state of residence. (19 data elements)
• COVID-19 Case Surveillance Public Use Data: Public use, patient-level dataset with clinical and symptom data and demographics, with no geographic data. (12 data elements)
• COVID-19 Case Surveillance Restricted Access Detailed Data: Restricted access, patient-level dataset with clinical and symptom data, demographics, and state and county of residence. Access requires a registration process and a data use agreement. (33 data elements)

The following apply to all three datasets:

• Data elements can be found on the COVID-19 case report form located at www.cdc.gov/coronavirus/2019-ncov/downloads/pui-form.pdf.
• Data are considered provisional by CDC and are subject to change until the data are reconciled and verified with the state and territorial data providers.
• Some data cells are suppressed to protect individual privacy.
• The datasets will include all cases with the earliest date available in each record (date received by CDC or date related to illness/specimen collection) at least 14 days prior to the creation of the current datasets. This 14-day lag allows case reporting to be stabilized and ensures that time-dependent outcome data are accurately captured.
• Datasets are updated monthly.
• Datasets are created using CDC’s Policy on Public Health Research and Nonresearch Data Management and Access and include protections designed to protect individual privacy.
• For more information about data collection and reporting, please see https://www.cdc.gov/coronavirus/2019-ncov/covid-data/about-us-cases-deaths.html.
• For more information about the COVID-19 case surveillance data, please see https://www.cdc.gov/coronavirus/2019-ncov/covid-data/faq-surveillance.html
  

Overview

The COVID-19 case surveillance database includes individual-level data reported to U.S. states and autonomous reporting entities, including New York City and the District of Columbia (D.C.), as well as U.S. territories and affiliates. On April 5, 2020, COVID-19 was added to the Nationally Notifiable Condition List and classified as “immediately notifiable, urgent (within 24 hours)” by a Council of State and Territorial Epidemiologists (CSTE) Interim Position Statement (Interim-20-ID-01). CSTE updated the position statement on August 5, 2020, to clarify the interpretation of antigen detection tests and serologic test results within the case classification (Interim-20-ID-02). The statement also recommended that all states and territories enact laws to make COVID-19 reportable in their jurisdiction, and that jurisdictions conducting surveillance should submit case notifications to CDC. COVID-19 case surveillance data are collected by jurisdictions and reported voluntarily to CDC.

For more information: NNDSS Supports the COVID-19 Response | CDC.

The deidentified data in the “COVID-19 Case Surveillance Public Use Data” include demographic characteristics, any exposure history, disease severity indicators and outcomes, clinical data, laboratory diagnostic test results, and presence of any underlying medical conditions and risk behaviors. All data elements can be found on the COVID-19 case report form located at www.cdc.gov/coronavirus/2019-ncov/downloads/pui-form.pdf.

COVID-19 Case Reports

COVID-19 case reports have been routinely submitted using nationally standardized case reporting forms. On April 5, 2020, CSTE released an Interim Position Statement with national surveillance case definitions for COVID-19 included. Current versions of these case definitions are available here: https://ndc.services.cdc.gov/case-definitions/coronavirus-disease-2019-2021/.

All cases reported on or after were requested to be shared by public health departments to CDC using the standardized case definitions for laboratory-confirmed or probable cases. On May 5, 2020, the standardized case reporting form was revised. Case reporting using this new form is ongoing among U.S. states and territories.

Data are Considered Provisional

• The COVID-19 case surveillance data are dynamic; case reports can be modified at any time by the jurisdictions sharing COVID-19 data with CDC. CDC may update prior cases shared with CDC based on any updated information from jurisdictions. For instance, as new information is gathered about previously reported cases, health departments provide updated data to CDC. As more information and data become available, analyses might find changes in surveillance data and trends during a previously reported time window. Data may also be shared late with CDC due to the volume of COVID-19 cases.
• Annual finalized data: To create the final NNDSS data used in the annual tables, CDC works carefully with the reporting jurisdictions to reconcile the data received during the year until each state or territorial epidemiologist confirms that the data from their area are correct.
• Access Addressing Gaps in Public Health Reporting of Race and Ethnicity for COVID-19, a report from the Council of State and Territorial Epidemiologists, to better understand the challenges in completing race and ethnicity data for COVID-19 and recommendations for improvement.

Data Limitations

To learn more about the limitations in using case surveillance data, visit FAQ: COVID-19 Data and Surveillance.

Data Quality Assurance Procedures

CDC’s Case Surveillance Section routinely performs data quality assurance procedures (i.e., ongoing corrections and logic checks to address data errors). To date, the following data cleaning steps have been implemented:

• Questions that have been left unanswered (blank) on the case report form are reclassified to a Missing value, if applicable to the question. For example, in the question “Was the individual hospitalized?” where the possible answer choices include “Yes,” “No,” or “Unknown,” the blank value is recoded to Missing because the case report form did not include a response to the question.
• Logic checks are performed for date data. If an illogical date has been provided, CDC reviews the data with the reporting jurisdiction. For example, if a symptom onset date in the future is reported to CDC, this value is set to null until the reporting jurisdiction updates the date appropriately.
• Additional data quality processing to recode free text data is ongoing. Data on symptoms, race and ethnicity, and healthcare worker status have been prioritized.

Data Suppression

To prevent release of data that could be used to identify people, data cells are suppressed for low frequency (<5) records and indirect identifiers (e.g., date of first positive specimen). Suppression includes rare combinations of demographic characteristics (sex, age group, race/ethnicity). Suppressed values are re-coded to the NA answer option; records with data suppression are never removed.

For questions, please contact Ask SRRG (eocevent394@cdc.gov).

Additional COVID-19 Data

COVID-19 data are available to the public as summary or aggregate count files, including total counts of cases and deaths by state and by county. These

Reporting of new Aggregate Case and Death Count data was discontinued May 11, 2023, with the expiration of the COVID-19 public health emergency declaration. This dataset will receive a final update on June 1, 2023, to reconcile historical data through May 10, 2023, and will remain publicly available.

Aggregate Data Collection Process Since the start of the COVID-19 pandemic, data have been gathered through a robust process with the following steps:

• A CDC data team reviews and validates the information obtained from jurisdictions’ state and local websites via an overnight data review process.
• If more than one official county data source exists, CDC uses a comprehensive data selection process comparing each official county data source, and takes the highest case and death counts respectively, unless otherwise specified by the state.
• CDC compiles these data and posts the finalized information on COVID Data Tracker.
• County level data is aggregated to obtain state and territory specific totals.

This process is collaborative, with CDC and jurisdictions working together to ensure the accuracy of COVID-19 case and death numbers. County counts provide the most up-to-date numbers on cases and deaths by report date. CDC may retrospectively update counts to correct data quality issues.

Methodology Changes Several differences exist between the current, weekly-updated dataset and the archived version:

• Source: The current Weekly-Updated Version is based on county-level aggregate count data, while the Archived Version is based on State-level aggregate count data.
• Confirmed/Probable Cases/Death breakdown:  While the probable cases and deaths are included in the total case and total death counts in both versions (if applicable), they were reported separately from the confirmed cases and deaths by jurisdiction in the Archived Version.  In the current Weekly-Updated Version, the counts by jurisdiction are not reported by confirmed or probable status (See Confirmed and Probable Counts section for more detail).
• Time Series Frequency: The current Weekly-Updated Version contains weekly time series data (i.e., one record per week per jurisdiction), while the Archived Version contains daily time series data (i.e., one record per day per jurisdiction).
• Update Frequency: The current Weekly-Updated Version is updated weekly, while the Archived Version was updated twice daily up to October 20, 2022.

Important note: The counts reflected during a given time period in this dataset may not match the counts reflected for the same time period in the archived dataset noted above. Discrepancies may exist due to differences between county and state COVID-19 case surveillance and reconciliation efforts.

Confirmed and Probable Counts In this dataset, counts by jurisdiction are not displayed by confirmed or probable status. Instead, confirmed and probable cases and deaths are included in the Total Cases and Total Deaths columns, when available. Not all jurisdictions report probable cases and deaths to CDC.* Confirmed and probable case definition criteria are described here:

Council of State and Territorial Epidemiologists (ymaws.com).

Deaths CDC reports death data on other sections of the website: CDC COVID Data Tracker: Home, CDC COVID Data Tracker: Cases, Deaths, and Testing, and NCHS Provisional Death Counts. Information presented on the COVID Data Tracker pages is based on the same source (total case counts) as the present dataset; however, NCHS Death Counts are based on death certificates that use information reported by physicians, medical examiners, or coroners in the cause-of-death section of each certificate. Data from each of these pages are considered provisional (not complete and pending verification) and are therefore subject to change. Counts from previous weeks are continually revised as more records are received and processed.

Number of Jurisdictions Reporting There are currently 60 public health jurisdictions reporting cases of COVID-19. This includes the 50 states, the District of Columbia, New York City, the U.S. territories of American Samoa, Guam, the Commonwealth of the Northern Mariana Islands, Puerto Rico, and the U.S Virgin Islands as well as three independent countries in compacts of free association with the United States, Federated States of Micronesia, Republic of the Marshall Islands, and Republic of Palau. New York State’s reported case and death counts do not include New York City’s counts as they separately report nationally notifiable conditions to CDC.

CDC COVID-19 data are available to the public as summary or aggregate count files, including total counts of cases and deaths, available by state and by county. These and other data on COVID-19 are available from multiple public locations, such as:

https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html

https://www.cdc.gov/covid-data-tracker/index.html

https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html

https://www.cdc.gov/coronavirus/2019-ncov/php/open-america/surveillance-data-analytics.html

Additional COVID-19 public use datasets, include line-level (patient-level) data, are available at: https://data.cdc.gov/browse?tags=covid-19.

Archived Data Notes:

November 3, 2022: Due to a reporting cadence issue, case rates for Missouri counties are calculated based on 11 days’ worth of case count data in the Weekly United States COVID-19 Cases and Deaths by State data released on November 3, 2022, instead of the customary 7 days’ worth of data.

November 10, 2022: Due to a reporting cadence change, case rates for Alabama counties are calculated based on 13 days’ worth of case count data in the Weekly United States COVID-19 Cases and Deaths by State data released on November 10, 2022, instead of the customary 7 days’ worth of data.

November 10, 2022: Per the request of the jurisdiction, cases and deaths among non-residents have been removed from all Hawaii county totals throughout the entire time series. Cumulative case and death counts reported by CDC will no longer match Hawaii’s COVID-19 Dashboard, which still includes non-resident cases and deaths. 

November 17, 2022: Two new columns, weekly historic cases and weekly historic deaths, were added to this dataset on November 17, 2022. These columns reflect case and death counts that were reported that week but were historical in nature and not reflective of the current burden within the jurisdiction. These historical cases and deaths are not included in the new weekly case and new weekly death columns; however, they are reflected in the cumulative totals provided for each jurisdiction. These data are used to account for artificial increases in case and death totals due to batched reporting of historical data.

December 1, 2022: Due to cadence changes over the Thanksgiving holiday, case rates for all Ohio counties are reported as 0 in the data released on December 1, 2022.

January 5, 2023: Due to North Carolina’s holiday reporting cadence, aggregate case and death data will contain 14 days’ worth of data instead of the customary 7 days. As a result, case and death metrics will appear higher than expected in the January 5, 2023, weekly release.

January 12, 2023: Due to data processing delays, Mississippi’s aggregate case and death data will be reported as 0. As a result, case and death metrics will appear lower than expected in the January 12, 2023, weekly release.

January 19, 2023: Due to a reporting cadence issue, Mississippi’s aggregate case and death data will be calculated based on 14 days’ worth of data instead of the customary 7 days in the January 19, 2023, weekly release.

January 26, 2023: Due to a reporting backlog of historic COVID-19 cases, case rates for two Michigan counties (Livingston and Washtenaw) were higher than expected in the January 19, 2023 weekly release.

January 26, 2023: Due to a backlog of historic COVID-19 cases being reported this week, aggregate case and death counts in Charlotte County and Sarasota County, Florida, will appear higher than expected in the January 26, 2023 weekly release.

January 26, 2023: Due to data processing delays, Mississippi’s aggregate case and death data will be reported as 0 in the weekly release posted on January 26, 2023.

February 2, 2023: As of the data collection deadline, CDC observed an abnormally large increase in aggregate COVID-19 cases and deaths reported for Washington State. In response, totals for new cases and new deaths released on February 2, 2023, have been displayed as zero at the state level until the issue is addressed with state officials. CDC is working with state officials to address the issue.

February 2, 2023: Due to a decrease reported in cumulative case counts by Wyoming, case rates will be reported as 0 in the February 2, 2023, weekly release. CDC is working with state officials to verify the data submitted.

February 16, 2023: Due to data processing delays, Utah’s aggregate case and death data will be reported as 0 in the weekly release posted on February 16, 2023. As a result, case and death metrics will appear lower than expected and should be interpreted with caution.

February 16, 2023: Due to a reporting cadence change, Maine’s

The Monthly Outcome Survey (MOS) was designed to assess COVID-19 vaccine uptake as well as beliefs, intentions, and behaviors relevant to COVID-19 vaccination at a point in time. The survey fielded on a monthly basis from January 2021 to April 2023. When the MOS first launched, it focused on the primary series of COVID-19 vaccines; in later waves, it was expanded to assess parents’ intentions to get their children vaccinated or boosted and to track booster and updated vaccine uptake and readiness. The MOS fielded as part of an online omnibus survey, conducted with a cross-sectional sample of approximately 5,000 U.S. adults each month.

The Netherlands has reached an endemic phase for the SARS-CoV-2 virus (coronavirus) and the GGD test lanes will be closed on March 17, 2023. As a result, the data will no longer be updated from 1 April 2023. File from week 40, 2021: COVID-19_casus_landelijk File up to and including week 39, 2021: COVID-19_casus_landelijk_tm This file will no longer be updated from version 5 (see below) Available formats: .csv and .json Source system: OSIRIS General Infectious Diseases (AIZ) ) File description: This file contains the following characteristics per positively tested case in the Netherlands: Date for statistics, Age group, Sex, Death, Week of death, Province, Notifying GGD The file is structured as follows: A record for each laboratory confirmed COVID-19 19 patient in the Netherlands since the start of the pandemic. From July 11, 2022, this data has been split (see description version 5). Only the file from week 40, 2021, will be updated every Tuesday and Friday at 4:00 PM, based on the data as registered at 10:00 AM that day in the national system for notifiable infectious diseases (Osiris AIZ). The historical file (up to and including week 39, 2021) will no longer be updated from July 11. Description of the variables: Version: Version number of the dataset. When the content of the dataset is structurally changed (so not the daily update or a correction at record level), the version number will be adjusted (+1) and also the corresponding metadata in RIVMdata (https://data.rivm.nl) . Version 2 update (January 20, 2022): - In version 2 of this dataset, the variable 'hospital_admission' is no longer available. For the number of hospital admissions, reference is made to the registered hospital admissions of the NICE Foundation (data.rivm.nl/covid-19/COVID-19_ziekenhuis Admissions.html). Version 3 update (February 8, 2022) - From February 8, 2022, the positive SARS-CoV-2 test results will be reported directly from CoronIT to RIVM. The test results of other test providers (such as Testing for Access) and healthcare institutions (such as hospitals, nursing homes and general practitioners) that enter their positive SARS-CoV-2 test results via the Reporting Portal of GGD GHOR are also reported directly to RIVM. Reports that are part of the source and contact investigation sample and positive SARS-CoV-2 test results from healthcare institutions that are reported to the GGD via healthcare email are reported to RIVM via HPZone. From February 8, the date of the positive test result is used and no longer the date of notification to the GGD Version 4 update (March 24, 2022): - In version 4 of this dataset, records have been compiled according to the municipality reclassification of March 24, 2022. See description of the Municipal_health_service variable for more information. Version 5 update (July 11, 2022): - As of July 11, 2022, this dataset has been split into two parts. The first part contains the dates from the start of the pandemic to October 3, 2021 (week 39) and contains "tm" in the file name. This data will no longer be updated. The second part contains the data from October 4, 2021 (week 40) and is updated every working day. Version 6 update (September 1, 2022): - From September 1, 2022, the second part of the data (from week 40 2021) will no longer be updated every working day, but on Tuesdays and Fridays. The data is retroactively updated on these days for the other days. Version 7 update (January 3, 2023): - As of January 1, 2023, RIVM will no longer collect additional information. As a result, we will no longer report deaths from January 1, 2023 and the [Deceased] and [Week of Death] columns will no longer be completed. Date_file: Date and time when the data was published by RIVM Date_statistics: Date for statistics; first day of illness, if not known, date lab positive, if not known, report date to GGD (format: yyyy-mm-dd) Date_statistics_type: Type of date that was available for date for the variable "Date voor statistic", where: DOO = Date of disease onset : First day of illness as reported by GGD. Please note: it is not always known whether this first day of illness actually concerned Covid-19. DPL = Date of first Positive Labresult : Date of the (first) positive labresult. DON = Date of Notification : Date on which the notification was received by the GGD. Agegroup: Age group alive; 0-9, 10-19, ..., 90+; at death <50, 50-59, 60-69, 70-79, 80-89, 90+, Unknown = Unknown Sex: Gender; Unknown = Unknown, Male = Male, Female = Female Province: Province name (based on patient's residence) Deceased: Death. Unknown = Unknown, Yes = Yes, No = No. From January 1, 2023, this column will be empty. Week of Death : Week of death. YYYYMM according to ISO week format (starts on Monday to Sunday). From January 1, 2023, this column will be empty. Municipal_health_service: GGD that made the report. From March 24, 2022, this file was compiled according to the municipality classification of March 24, 2022. The municipality of Weesp was merged into the municipality of Amsterdam. With this division, the Gooi- en Vechtstreek safety region has become smaller and the Amsterdam-Amstelland safety region larger; GGD Amsterdam has become larger and GGD Gooi- en Vechtstreek has become smaller (https://www.cbs.nl/nl-nl/onze-diensten/methods/classifications/overig/gemeentelijke-delingen-per-jaar/deling-per -year/municipal-division-on-1-January-2022). -------------------------------------------------- --------------------------------------------- Covid-19 characteristics per case, nationwide The Netherlands has reached an endemic phase for the SARS-CoV -2 virus (coronavirus) and the PHS testing facilities will be closed as of March 17, 2023. As a result, the data will no longer be updated from April 1, 2023. File from week 40, 2021: COVID-19_case_landelijk File up to and including week 39, 2021: COVID-19_casus_landelijk_tm This file will no longer be updated from version 5 (see below) Available formats: .csv and .json Source system: OSIRIS General Infectious Diseases (AIZ) File description: This file contains the following Characteristics per positively tested case in the Netherlands: Date for statistics, Age group, Gender, Death, Week of death, Province, Notifying PHS The file is structured as follows: A record for every lab-confirmed COVID-19 patient in the Netherlands since the start of the pandemic. From July 11, 2022, this data has been split (see description version 5). Only the file from week 40, 2021 onwards will be updated every Tuesday and Friday at 4:00 PM, based on the data as registered at 10:00 AM that day in the national system for notifiable infectious diseases (Osiris AIZ). The historical file (up to and including week 39, 2021) will no longer be updated from July 11, 2022. Description of the variables: Version: Version number of the dataset. When the content of the dataset is structurally changed (so not the daily update or a correction at record level), the version number will be adjusted (+1) and also the corresponding metadata in RIVMdata (https://data.rivm.nl ). Version 2 update (January 20, 2022): - In version 2 of this dataset, the variable 'hospital_admission' is no longer available. For the number of hospital admissions, reference is made to the registered hospital admissions of the NICE Foundation (data.rivm.nl/covid-19/COVID-19_ziekenhuis Admissions.html). Version 3 update (February 8, 2022) - From 8 February 2022, positive SARS-CoV-2 test results will be reported directly from CoronIT to the RIVM. The test results of other test providers (such as Testing for Access) and healthcare institutions (such as hospitals, nursing homes and general practitioners) that enter their positive SARS-CoV-2 test results via the Reporting Portal of GGD GHOR are also reported directly to the RIVM. Reports that are part of the source and contact investigation sample and positive SARS-CoV-2 test results from healthcare institutions that are reported to the PHS via healthcare email are reported to the RIVM via HPZone. From 8 February 2022, the date of the positive test result is used and no longer the date of notification to the PHS. Version 4 update (March 24, 2022): - In version 4 of this dataset, records are compiled according to the municipality reclassification of March 24, 2022. See description of the Municipal_health_service variable for more information. Version 5 Update (July 11, 2022): - As of July 11, 2022, this dataset is split into two parts. The first part contains the dates from the start of the pandemic to October 3, 2021 (week 39) and contains "tm" in the file name. This data will no longer be updated. The second part contains the data from October 4, 2021 (week 40) and is updated every working day. Version 6 update (September 1, 2022): - From September 1, 2022, the second part of the data (from week 40 2021) will no longer be updated every working day, but on Tuesdays and Fridays. The data is retroactively updated on these days for the other days. Version 7 update (January 3, 2023): - As of 1 January 2023, the RIVM will no longer collect additional information. As a result, we will no longer report deaths from January 1, 2023 and the [Deceased] and [Week of Death] columns will no longer be completed. Date_file: Date and time when the data was published by the RIVM Date_statistics: Date for statistics; first day of illness, if not known, date of positive lab result, if not known, reporting date to PHS (format: yyyy-mm-dd) Date_statistics_type: Type of date that was available for date for the "Date for statistics" variable , where: DOO = Date of disease onset : First day of illness as reported by PHS. Please note: it is not always known whether this first day of illness actually concerned Covid-19. DPL = Date of first Positive Lab result : Date of the (first) positive lab result. DON = Date of Notification : Date on which the notification was received by the PHS. Agegroup: Age group alive; 0-9, 10-19, ..., 90+; at death

Note: After May 3, 2024, this dataset will no longer be updated because hospitals are no longer required to report data on COVID-19 hospital admissions, hospital capacity, or occupancy data to HHS through CDC’s National Healthcare Safety Network (NHSN). The related CDC COVID Data Tracker site was revised or retired on May 10, 2023.

Note: May 3,2024: Due to incomplete or missing hospital data received for the April 21,2024 through April 27, 2024 reporting period, the COVID-19 Hospital Admissions Level could not be calculated for CNMI and will be reported as “NA” or “Not Available” in the COVID-19 Hospital Admissions Level data released on May 3, 2024.

This dataset represents COVID-19 hospitalization data and metrics aggregated to county or county-equivalent, for all counties or county-equivalents (including territories) in the United States as of the initial date of reporting for each weekly metric. COVID-19 hospitalization data are reported to CDC’s National Healthcare Safety Network, which monitors national and local trends in healthcare system stress, capacity, and community disease levels for approximately 6,000 hospitals in the United States. Data reported by hospitals to NHSN and included in this dataset represent aggregated counts and include metrics capturing information specific to COVID-19 hospital admissions, and inpatient and ICU bed capacity occupancy.

Reporting information:

• As of December 15, 2022, COVID-19 hospital data are required to be reported to NHSN, which monitors national and local trends in healthcare system stress, capacity, and community disease levels for approximately 6,000 hospitals in the United States. Data reported by hospitals to NHSN represent aggregated counts and include metrics capturing information specific to hospital capacity, occupancy, hospitalizations, and admissions. Prior to December 15, 2022, hospitals reported data directly to the U.S. Department of Health and Human Services (HHS) or via a state submission for collection in the HHS Unified Hospital Data Surveillance System (UHDSS).
• While CDC reviews these data for errors and corrects those found, some reporting errors might still exist within the data. To minimize errors and inconsistencies in data reported, CDC removes outliers before calculating the metrics. CDC and partners work with reporters to correct these errors and update the data in subsequent weeks.
• Many hospital subtypes, including acute care and critical access hospitals, as well as Veterans Administration, Defense Health Agency, and Indian Health Service hospitals, are included in the metric calculations provided in this report. Psychiatric, rehabilitation, and religious non-medical hospital types are excluded from calculations.
• Data are aggregated and displayed for hospitals with the same Centers for Medicare and Medicaid Services (CMS) Certification Number (CCN), which are assigned by CMS to counties based on the CMS Provider of Services files.
• Full details on COVID-19 hospital data reporting guidance can be found here: https://www.hhs.gov/sites/default/files/covid-19-faqs-hospitals-hospital-laboratory-acute-care-facility-data-reporting.pdf

Calculation of county-level hospital metrics:

• County-level hospital data are derived using calculations performed at the Health Service Area (HSA) level. An HSA is defined by CDC’s National Center for Health Statistics as a geographic area containing at least one county which is self-contained with respect to the population’s provision of routine hospital care. Every county in the United States is assigned to an HSA, and each HSA must contain at least one hospital. Therefore, use of HSAs in the calculation of local hospital metrics allows for more accurate characterization of the relationship between health care utilization and health status at the local level.
• Data presented at the county-level represent admissions, hospital inpatient and ICU bed capacity and occupancy among hospitals within the selected HSA. Therefore, admissions, capacity, and occupancy are not limited to residents of the selected HSA.
• For all county-level hospital metrics listed below the values are calculated first for the entire HSA, and then the HSA-level value is then applied to each county within the HSA.
• For all county-level hospital metrics listed below the values are calculated first for the entire HSA, and then the HSA-level value is then applied to each county within the HSA.

Metric details:

• Time period: data for the previous MMWR week (Sunday-Saturday) will update weekly on Mondays as soon as they are reviewed and verified, usually before 8 pm ET. Updates will occur the following day when reporting coincides with a federal holiday. Note: Weekly updates might be delayed due to delays in reporting. All data are provisional. Because these provisional counts are subject to change, including updates to data reported previously, adjustments can occur. Data may be updated since original publication due to delays in reporting (to account for data received after a given Thursday publication) or data quality corrections.
• New hospital admissions (count): Total number of admissions of patients with laboratory-confirmed COVID-19 in the previous week (including both adult and pediatric admissions) in the entire jurisdiction
• New Hospital Admissions Rate Value (Admissions per 100k): Total number of new admissions of patients with laboratory-confirmed COVID-19 in the past week (including both adult and pediatric admissions) for the entire jurisdiction divided by 2019 intercensal population estimate for that jurisdiction multiplied by 100,000. (Note: This metric is used to determine each county’s COVID-19 Hospital Admissions Level for a given week).
• New COVID-19 Hospital Admissions Rate Level: qualitative value of new COVID-19 hospital admissions rate level [Low, Medium, High, Insufficient Data]
• New hospital admissions percent change from prior week: Percent change in the current weekly total new admissions of patients with laboratory-confirmed COVID-19 per 100,000 population compared with the prior week.
• New hospital admissions percent change from prior week level: Qualitative value of percent change in hospital admissions rate from prior week [Substantial decrease, Moderate decrease, Stable, Moderate increase, Substantial increase, Insufficient data]
• COVID-19 Inpatient Bed Occupancy Value: Percentage of all staffed inpatient beds occupied by patients with laboratory-confirmed COVID-19 (including both adult and pediatric patients) within the in the entire jurisdiction is calculated as an average of valid daily values within the past week (e.g., if only three valid values, the average of those three is taken). Averages are separately calculated for the daily numerators (patients hospitalized with confirmed COVID-19) and denominators (staffed inpatient beds). The average percentage can then be taken as the ratio of these two values for the entire jurisdiction.
• COVID-19 Inpatient Bed Occupancy Level: Qualitative value of inpatient beds occupied by COVID-19 patients level [Minimal, Low, Moderate, Substantial, High, Insufficient data]
• COVID-19 Inpatient Bed Occupancy percent change from prior week: The absolute change in the percent of staffed inpatient beds occupied by patients with laboratory-confirmed COVID-19 represents the week-over-week absolute difference between the average occupancy of patients with confirmed COVID-19 in staffed inpatient beds in the past week, compared with the prior week, in the entire jurisdiction.
• COVID-19 ICU Bed Occupancy Value: Percentage of all staffed inpatient beds occupied by adult patients with confirmed COVID-19 within the entire jurisdiction is calculated as an average of valid daily values within the past week (e.g., if only three valid values, the average of those three is taken). Averages are separately calculated for the daily numerators (adult patients hospitalized with confirmed COVID-19) and denominators (staffed adult ICU beds). The average percentage can then be taken as the ratio of these two values for the entire jurisdiction.
• COVID-19 ICU Bed Occupancy Level: Qualitative value of ICU beds occupied by COVID-19 patients level [Minimal, Low, Moderate, Substantial, High, Insufficient data]
• COVID-19 ICU Bed Occupancy percent change from prior week: The absolute change in the percent of staffed ICU beds occupied by patients with laboratory-confirmed COVID-19 represents the week-over-week absolute difference between the average occupancy of patients with confirmed COVID-19 in staffed adult ICU beds for the past week, compared with the prior week, in the in the entire jurisdiction.
• For all metrics, if there are no data in the specified locality for a given week, the metric value is displayed as “insufficient data”.

Notes: June 15, 2023: Due to incomplete or missing hospital data received for the June 4, 2023, through June 10, 2023, reporting period, the COVID-19 Hospital Admissions Level could not be calculated for CNMI and AS and will be reported as “NA” or “Not Available” in the COVID-19 Hospital Admissions Level data released on June 15, 2023.

July 10, 2023: Due to incomplete or missing hospital data received for the June 25, 2023, through July 1, 2023, reporting period, the COVID-19 Hospital Admissions Level could not be calculated for CNMI and AS and will be reported as “NA” or “Not Available” in the COVID-19 Hospital Admissions Level data released on July 10, 2023.

July 17, 2023: Due to incomplete or missing hospital data received for the July 2, 2023, through July 8, 2023, reporting

As of April 26, 2023, roughly 675 million COVID-19 vaccine doses had been administered in the United States. This statistic shows the number of COVID-19 vaccine doses administered in the United States as of April 26, 2023, by state or territory.

China COVID-19: Confirmed Case: Severe Case: Preexisting Illnesses Combined with COVID-19 data was reported at 16.000 Person in 27 Apr 2023. This records an increase from the previous number of 8.000 Person for 20 Apr 2023. China COVID-19: Confirmed Case: Severe Case: Preexisting Illnesses Combined with COVID-19 data is updated daily, averaging 8.000 Person from Jan 2023 (Median) to 27 Apr 2023, with 15 observations. The data reached an all-time high of 96,661.000 Person in 12 Jan 2023 and a record low of 4.000 Person in 13 Apr 2023. China COVID-19: Confirmed Case: Severe Case: Preexisting Illnesses Combined with COVID-19 data remains active status in CEIC and is reported by Chinese Center for Disease Control and Prevention. The data is categorized under China Premium Database’s Socio-Demographic – Table CN.GZ: COVID-19: No of Patient.

Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes

Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022.

Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases among people who received additional or booster doses were reported from 31 jurisdictions; 30 jurisdictions also reported data on deaths among people who received one or more additional or booster dose; 28 jurisdictions reported cases among people who received two or more additional or booster doses; and 26 jurisdictions reported deaths among people who received two or more additional or booster doses. This list will be updated as more jurisdictions participate. Incidence rate estimates: Weekly age-specific incidence rates by vaccination status were calculated as the number of cases or deaths divided by the number of people vaccinated with a primary series, overall or with/without a booster dose (cumulative) or unvaccinated (obtained by subtracting the cumulative number of people vaccinated with a primary series and partially vaccinated people from the 2019 U.S. intercensal population estimates) and multiplied by 100,000. Overall incidence rates were age-standardized using the 2000 U.S. Census standard population. To estimate population counts for ages 6 months through 1 year, half of the single-year population counts for ages 0 through 1 year were used. All rates are plotted by positive specimen collection date to reflect when incident infections occurred. For the primary series analysis, age-standardized rates include ages 12 years and older from April 4, 2021 through December 4, 2021, ages 5 years and older from December 5, 2021 through July 30, 2022 and ages 6 months and older from July 31, 2022 onwards. For the booster dose analysis, age-standardized rates include ages 18 years and older from September 19, 2021 through December 25, 2021, ages 12 years and older from December 26, 2021, and ages 5 years and older from June 5, 2022 onwards. Small numbers could contribute to less precision when calculating death rates among some groups. Continuity correction: A continuity correction has been applied to the denominators by capping the percent population coverage at 95%. To do this, we assumed that at least 5% of each age group would always be unvaccinated in each jurisdiction. Adding this correction ensures that there is always a reasonable denominator for the unvaccinated population that would prevent incidence and death rates from growing unrealistically large due to potential overestimates of vaccination coverage. Incidence rate ratios (IRRs): IRRs for the past one month were calculated by dividing the average weekly incidence rates among unvaccinated people by that among people vaccinated with a primary series either overall or with a booster dose. Publications: Scobie HM, Johnson AG, Suthar AB, et al. Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1284–1290. Johnson AG, Amin AB, Ali AR, et al. COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021. MMWR Morb Mortal Wkly Rep 2022;71:132–138. Johnson AG, Linde L, Ali AR, et al. COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022. MMWR Morb Mortal Wkly Rep 2023;72:145–152. Johnson AG, Linde L, Payne AB, et al. Notes from the Field: Comparison of COVID-19 Mortality Rates Among Adults Aged ≥65 Years Who Were Unvaccinated and Those Who Received a Bivalent Booster Dose Within the Preceding 6 Months — 20 U.S. Jurisdictions, September 18, 2022–April 1, 2023. MMWR Morb Mortal Wkly Rep 2023;72:667–669.

Abstract

After implementing Phase 1 of the High-Frequency Phone Survey (HFPS) project in Latin America and The Caribbean in 2020, the World Bank conducted Phase 2 in 2021 to continue to assess the socio-economic impacts of the COVID-19 pandemic on households. The Phase 2, conducted in partnership with the UNDP LAC Chief Economist office, included two waves. Wave 1 covering 24 countries. Wave 2 collected between October and December 2021, covering 22 countries. Of these countries, 13 participated in Phase 1: Argentina, Bolivia, Colombia, Costa Rica, Chile, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Paraguay and Peru. Countries that joined in Phase 2 are: Antigua & Barbuda and Brazil (only in Wave 1), Belize, Dominica, Guyana, Haiti, Jamaica, Nicaragua, Panama, St. Lucia and Uruguay. Wave 4 collected in Haiti between March and April 2023 is a follow-up initiative to the two waves of data collection that occurred in 2021 and 2022.

Geographic coverage

National level

Analysis unit

Households and individuals of 18 years of age and older.

Sampling procedure

The size of the selected global sample of telephone numbers for Wave 4 (cellular and landline phones) was based on the previous procedures carried out in phases 1 and 2 in order to collect information for about 1,500 individuals. Please see Sampling Design and Weighting document for more detail on sampling procedures for phases 1 and 2.

Mode of data collection

Computer Assisted Telephone Interview [cati]

Research instrument

Questionnaires are available for download in English.

China COVID-19: Vaccinated Rate: To-Date data was reported at 93.000 % in 27 Apr 2023. This stayed constant from the previous number of 93.000 % for 20 Apr 2023. China COVID-19: Vaccinated Rate: To-Date data is updated daily, averaging 92.090 % from Aug 2021 (Median) to 27 Apr 2023, with 52 observations. The data reached an all-time high of 93.000 % in 27 Apr 2023 and a record low of 76.000 % in 26 Aug 2021. China COVID-19: Vaccinated Rate: To-Date data remains active status in CEIC and is reported by National Health Commission. The data is categorized under China Premium Database’s Socio-Demographic – Table CN.GZ: COVID-19: Vaccination.

China COVID-19: Vaccinated People: Age 60 and Above: Complete: To-Date data was reported at 230.372 Person mn in 27 Apr 2023. This records an increase from the previous number of 230.361 Person mn for 20 Apr 2023. China COVID-19: Vaccinated People: Age 60 and Above: Complete: To-Date data is updated daily, averaging 222.164 Person mn from Nov 2021 (Median) to 27 Apr 2023, with 54 observations. The data reached an all-time high of 230.372 Person mn in 27 Apr 2023 and a record low of 206.317 Person mn in 29 Nov 2021. China COVID-19: Vaccinated People: Age 60 and Above: Complete: To-Date data remains active status in CEIC and is reported by National Health Commission. The data is categorized under China Premium Database’s Socio-Demographic – Table CN.GZ: COVID-19: Vaccination.

The Monthly Outcome Survey (MOS) was designed to assess COVID-19 vaccine uptake as well as beliefs, intentions, and behaviors relevant to COVID-19 vaccination at a point in time. The survey fielded on a monthly basis from January 2021 to April 2023. When the MOS first launched, it focused on the primary series of COVID-19 vaccines; in later waves, it was expanded to assess parents’ intentions to get their children vaccinated or boosted and to track booster and updated vaccine uptake and readiness. The MOS fielded as part of an online omnibus survey, conducted with a cross-sectional sample of approximately 5,000 U.S. adults each month.

These tables will stop being updated after June 1, 2023. COVID-19 vaccination reporting is expected to resume when a new COVID-19 vaccination formulation is authorized. As 4/22/2023, CDC recommends bivalent vaccine for everyone regardless of age and whether or not the person has had prior monovalent vaccine. This table shows the cumulative number and percentage of people who have received an updated (bivalent) COVID-19 vaccination by race/ethnicity and age group for people 5 years and over. • Data are reported weekly on Thursday and include doses administered to Saturday of the previous week. • All data in this report are preliminary. Data for previous weeks may be changed because of delays in reporting, deduplication, or correction of errors. • The table groups people based on their current age and excludes people known to be deceased. • The analyses here are based on data reported to CT WiZ which is the immunization information system for CT. Connecticut COVID-19 Vaccine Program providers are required to report to CT WiZ all COVID-19 doses administered in CT including to CT residents and to residents of other jurisdictions. CT Wiz also receives records on CT residents vaccinated in other jurisdictions and by federal entities which share data with CT WiZ electronically (currently: RI, NJ, New York City, DE, Philadelphia, NV, Indian Health Service, Department of Veterans Affairs (doses administered since 11/2022)). Electronic data exchange is being added jurisdiction-by-jurisdiction. Once a jurisdiction is added to CT WiZ, the records for residents of that jurisdiction vaccinated in CT are removed. For example, when CT residents vaccinated in NYC were added, NYC residents vaccinated in CT were removed. • Population size estimates used to calculate cumulative percentages are based on 2020 DPH provisional census estimates*. • Race and ethnicity data may be self-reported or taken from an existing electronic health care record. Reported race and ethnicity information is used to create a single race/ethnicity variable. People with Hispanic ethnicity are classified as Hispanic regardless of reported race. People with a missing ethnicity are classified as non-Hispanic. People with more than one race are classified as multiple races. A vaccine coverage percentage cannot be calculated for people classified as NH (non-Hispanic) Other race or NH Unknown race since there are no population size estimates for these groups. Data quality assurance activities suggest that in at least some cases NH Other may represent a missing value. Vaccine coverage estimates in specific race/ethnicity groups may be underestimated as result of the classification of records as NH Unknown Race or NH Other Race. • Cumulative percentage estimates have been capped at 100%. Observed percentages may be higher than 100% for multiple reasons, inaccuracies in the census denominators or reporting errors. DPH Provisional State and County Characteristics Estimates April 1, 2020. Hayes L, Abdellatif E, Jiang Y, Backus K (2022) Connecticut DPH Provisional April 1, 2020, State Population Estimates by 18 age groups, sex, and 6 combined race and ethnicity groups. Connecticut Department of Public Health, Health Statistics & Surveillance, SAR, Hartford, CT.

According to a survey on food delivery apps conducted by Rakuten Insight in April 2023, about 60 percent of respondents from Taiwan said they ordered more from food delivery apps during the coronavirus (COVID-19) pandemic. Meanwhile, about a third of the respondents felt no impact of the pandemic on their food delivery app usage.

China COVID-19: Vaccinated People: Booster Shots: To-Date data was reported at 827.904 Person mn in 27 Apr 2023. This records an increase from the previous number of 827.839 Person mn for 20 Apr 2023. China COVID-19: Vaccinated People: Booster Shots: To-Date data is updated daily, averaging 793.279 Person mn from Nov 2021 (Median) to 27 Apr 2023, with 51 observations. The data reached an all-time high of 827.904 Person mn in 27 Apr 2023 and a record low of 37.973 Person mn in 05 Nov 2021. China COVID-19: Vaccinated People: Booster Shots: To-Date data remains active status in CEIC and is reported by National Health Commission. The data is categorized under China Premium Database’s Socio-Demographic – Table CN.GZ: COVID-19: Vaccination.